Skip to main content
OpenTrials
Completed

NCT Number: NCT00141128

Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.

SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Stress urinary incontinence

Exclusion criteria

  • Bladder outflow obstruction
  • Neurological disease

Treatment and study plan

SS-RBX

Drug

Primary outcomes

  1. To assess the utility of urethral reflectometry in the detection of pharmacologically induced pressure changes in the female urethra.

Secondary outcomes

  1. To assess the effect of [S,S]-Reboxetine on urethral function in women with SUI.

Sponsors and collaborators

Lead sponsor

Pfizer

Industry

Registry information

Official study title

Measurement Of Urethral Function In Women With Stress Urinary Incontinence - Evaluation Of The Sensitivity Of Urethral Reflectometry Compared To Urethral Pressure Profilometry, Using [S,S]-Reboxetine To Detect Pharmacological Augmentation Of Urethral Pressure.

Important dates

Study start
2005
Study completion
2006
First posted
Sep 1, 2005
Registry last updated
Jun 1, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.